Cyclooxygenase-2-dependent generation of 8-epiprostaglandin F(2α) by lipopolysaccharide-activated J774 macrophages

Inflammation Research

Volumn 48, Issue 9, 1999, Pages 503-508

  Sautebin, L ^a   Ianaro, A ^a   Rombola L ^a   Ialenti, A ^a   Sala, A ^b   Di Rosa, M ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

Author keywords

Cyclooxygenase; Isoprostanes; Lipopolysaccharide; Macrophages; Prostaglandins

Indexed keywords

3 (3 FLUOROPHENYL) 5,5 DIMETHYL 4 (4 METHYLSULFONYLPHENYL) 2(5H) FURANONE; 6 OXOPROSTAGLANDIN F1 ALPHA; 8 ISOPROSTAGLANDIN F2 ALPHA; ARACHIDONIC ACID; CYCLOHEXIMIDE; CYCLOOXYGENASE 2; DEXAMETHASONE; LIPOPOLYSACCHARIDE; PROSTAGLANDIN E2;

ANIMAL CELL; ARTICLE; CELL ACTIVATION; CELL LINE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CULTURE MEDIUM; ENZYME IMMUNOASSAY; IMMUNOSTIMULATION; MACROPHAGE; MONOCYTE; MOUSE; NONHUMAN; PROSTAGLANDIN RELEASE; RADIOIMMUNOASSAY;

6-KETOPROSTAGLANDIN F1 ALPHA; ANIMALS; ARACHIDONIC ACID; CELL LINE; CYCLOHEXIMIDE; CYCLOOXYGENASE 2; DEXAMETHASONE; DINOPROST; DINOPROSTONE; GLUCOCORTICOIDS; ISOENZYMES; LIPOPOLYSACCHARIDES; MACROPHAGE ACTIVATION; MACROPHAGES; MICE; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; PROTEIN SYNTHESIS INHIBITORS;

EID: 0032819127     PISSN: 10233830     EISSN: None     Source Type: Journal    
DOI: 10.1007/s000110050494     Document Type: Article

References (37)

1. Smith WL, Dewitt DL. Biochemistry of prostaglandin endoperoxide h synthase-1 and synthase-2 and their differential susceptibility to nonsteroidal anti-inflammatory drugs. Semin Nephrol 1995; 15: 179-94.
2. 2-like compounds are produced in vivo in humans by a non-cyclooxygenase, free radical-catalyzed mechanism. Proc Natl Acad Sci USA 1990; 87: 9383-7.
3. Morrow JD, Harris T, Roberts II LJ. Non-cyclooxygenase oxidative formation of a serie of novel prostaglandins: analytical ramification for measurement of eicosanoids. Anal Biochem 1990; 184: 1-10.
4. 2-isoprostanes) in plasma and low density lipoprotein exposed to oxidative stress in vitro. J Clin Invest 1994; 93: 998-1004.
5. 2-isoprostanes) in smokers. Smoking as a cause of oxidative damage. N Engl J Med 1995; 332: 1198-203.
6. 2-isoprostanes) in carbon tetrachloride hepatotoxicity. J Clin Invest 1992; 90: 2502-7.
7. 2-isoprostanes) in the hepatorenal syndrome. J Lipid Mediat 1993; 6: 417-20.
8. 2α is increased in hypercholcsterolemia. Arterioscler Thromb Vasc Biol 1997; 17: 3230-5.
9. 2 receptors. J Clin Invest 1992; 90: 136-41.
10. 2-isoprostanes receptors on rat vascular smooth muscle cells. Am J Physiol 1993; 264: C1619-24.
11. 2α in rabbit lung in situ. Am J Physiol 1992; 263: H660-3.
12. 2α in rat pulmonary artery. Br J Pharmacol 1997; 120: 1280-5.
13. 2α. J Biol Chem 1995; 270: 9800-8.
14. 2α by human monocytes. J Biol Chem 1996; 271: 8919-24.
15. 2-isoprostane formation. Br J Pharmacol 1996; 118: 1285-93.
16. 2α in vitro and in vivo via the cyclooxygenase. J Pharmacol Exp Ther 1997; 282: 1658-65.
17. Swierkosz TA, Mitchell JA, Warner TD, Bolting RM, Vane JR. Co-induction of nitric oxide synthase and cyclooxygenase: interactions between nitric oxide and prostanoids. Br J Pharmacol 1995; 114: 1335-42.
18. Zingarelli B, Southan GJ, Gilad E. O'Connor M, Salzman AL, Szabo C. The inhibitory effects of merkaptoalkylguanidines on cyclooxygenase activity. Br J Pharmacol 1997; 120: 357-66.
19. Riendeau D, Percival MD, Boyce S, Brideau C, Charleson S, Cromlish W, et al. Biochemical and pharmacological profile of a tetrasubstituted furanone as a highly selective COX-2 inhibitor. Br J Pharmacol 1997; 121:105-17.
20. 2α excretion in man. J Pharmacol Exp Ther 1995; 275: 94-100.
21. 2α in human urine. J Endocrinol Invest 1979; 2: 173-82.
22. Pradelles P, Grassy J, Maclouf J. Enzyme immunoassay of eicosanoids using acethylcholine esterase as label: an alternative to radioimmunoassay. Anal Chem 1985; 57: 1170-3.
23. Creminon C, Frobert Y, Habib A, MacLouf J, Pradelles P, Grassi J. Immunological studies of human constitutive cyclooxygenase-1 (COX-1) using enzyme immunometric assay. Biochim Biophys Acta 1995; 1254: 333-40.
24. Habib A, Creminon C, Frobert Y, Grassi J, Pradelles P, Maclouf J. Demonstration of an inducible cyclooxygenase in human endothelial cells using antibodies raised against the carboxyl-terminal region of the cyclooxygenase-2. J Biol Chem 1993; 268: 23448-54.
25. Mitchell JA, Akarasereenont P, Thiemermann C, Flower RJ, Vane JR. Selectivity of nonsteroidal antiinflammatory drugs as inhibitors of constitutive and inducible cyclooxygenase. Proc Natl Acad Sci USA 1994; 90: 11693-7.
26. Masferrer JL, Zweifel BS, Seibert K, Needleman P. Endogenous glucocorticoids regulate an inducible cyclooxygenase enzyme. Proc Natl Acad Sci USA 1992; 89: 3917-21.
27. D'Acquisto F, Iuvone T, Rombolà L, Sautebin L, Di Rosa M, Carnuccio R. Involvment of NF-kappaB in the regulation of cyclooxygenase-2 protein expression in LPS-stimulated J774 macrophages. FEBS Lett 1995; 418: 175-8.
28. Hajjar DP, Pomerantz HB. Signal transduction in atherosclerosis: integration of cytokines and eicosanoids network. FASEB J 1992; 6: 933-2941.
29. Fitzsimmons C, Proudfoot D, Bowyer DE. Monocyte prostaglandins inhibit procollagen secretion by human vascular smooth muscle cells: implications for plaques stability. Atherosclerosis 1999; 142: 287-93.
30. Gryglewski RJ. Interactions between endothelial mediators. Pharmacol Toxicol 1995; 77:1-9.
31. Hajjar DP, Weksler BB, Falcone DJ, Hefton JM, Tack-Goldman K, Minick CR. Prostacyclin modulates cholesteryl ester hydrolytic activity by its effect on cyclic adenosine monophosphate in rabbit aortic smooth muscle cells. J Clin Invest 1982; 70: 479-88.
32. 2 production in isolated human pulmonary artery smooth muscle cells; concomitant and differential release. FASEB J 1999; 13: 1025-30.
33. 2-isoprostanes in human atherosclerotic lesions. J Clin Invest 1997; 100: 2028-34.
34. 2-isoprostanes, are present in increased amounts in human atherosclerotic lesions. Arterioscler Thromb Vasc Biol 1997; 17: 3236-41.
35. Baker CS, Hall RJ, Evance TJ, Pomerance A, Maclouf J, Creminon C, et al. Cyclooxygenase-2 is widely expressed in atherosclerotic lesions affecting native and transplanted human coronary arteries and colocalizes with an inducible nitric oxide synthase and nitrotyrosine particularly in macrophages. Arterioscler Thromb Vasc Biol 1999; 19:646-55.
36. 2-isoprostanes to plaque instability in human carotid atherosclerosis. J Clin Invest 1999; 103: 421-7.
37. Fogelman AM, Van Lenten BJ, Warden C, Haberland ME, Edwards PA. Macrophages lipoprotein receptors. J Cell Sci Suppl 1988; 9: 135-49.